Clinical trial
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in…
NCT00111345 · University Hospital Muenster, Other · Unknown status
Key facts
| NCT number | NCT00111345 |
|---|---|
| Title | Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents |
| Official title | Multicenter Therapy-Optimization Trial AML-BFM 2004 for the Treatment of Acute Myeloid Leukemias in Children and Adolescents |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Deutsche Krebshilfe e.V., Bonn (Germany) |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Anthracyclines, liposomal daunorubicin, 2-CDA, AI |
| Enrollment | 550 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2017 |
| First posted | May 20, 2005 |
| Last update posted | May 23, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: